ImmuPharma PLC (UK) Price on September 4, 2024
| IMM Stock | 1.19 0.24 16.78% |
Below is the normalized historical share price chart for ImmuPharma PLC extending back to October 28, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ImmuPharma PLC stands at 1.19, as last reported on the 2nd of December, with the highest price reaching 1.45 and the lowest price hitting 1.17 during the day.
If you're considering investing in ImmuPharma Stock, it is important to understand the factors that can impact its price. ImmuPharma PLC holds Efficiency (Sharpe) Ratio of -0.0795, which attests that the entity had a -0.0795% return per unit of risk over the last 3 months. ImmuPharma PLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ImmuPharma PLC's Market Risk Adjusted Performance of (0.90), standard deviation of 3.62, and Risk Adjusted Performance of (0.05) to validate the risk estimate we provide.
At present, ImmuPharma PLC's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 30.8 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 2.6 M. . ImmuPharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.8751 | 50 Day MA 1.7267 | Beta 1.581 |
ImmuPharma |
Sharpe Ratio = -0.0795
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMM |
Estimated Market Risk
| 3.61 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ImmuPharma PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmuPharma PLC by adding ImmuPharma PLC to a well-diversified portfolio.
Price Book 1.8337 | Book Value 0.006 | Enterprise Value 4.7 M | Enterprise Value Ebitda (0.94) | Price Sales 60.7506 |
Related Headline
Federal Realty Headline on 4th of September 2024
Federal Realty shares maintain Neutral rating as analyst ups... by news.google.com
Federal Realty shares maintain Neutral rating as analyst ups target price after 2Q results Investing.com
ImmuPharma PLC Valuation on September 4, 2024
It is possible to determine the worth of ImmuPharma PLC on a given historical date. On September 4, 2024 ImmuPharma was worth 1.58 at the beginning of the trading date compared to the closed value of 1.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ImmuPharma PLC stock. Still, in general, we apply an absolute valuation method to find ImmuPharma PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ImmuPharma PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ImmuPharma PLC's related companies.
| Open | High | Low | Close | Volume | |
| 1.44 | 1.50 | 1.44 | 1.50 | 851,009 | |
09/04/2024 | 1.58 | 1.58 | 1.45 | 1.51 | 997,745 |
| 1.47 | 1.50 | 1.47 | 1.48 | 1,098,569 |
| Backtest ImmuPharma PLC | | | ImmuPharma PLC History | | | ImmuPharma PLC Valuation | Previous | Next |
ImmuPharma PLC Trading Date Momentum on September 4, 2024
| On September 05 2024 ImmuPharma PLC was traded for 1.48 at the closing time. The highest price during the trading period was 1.50 and the lowest recorded bid was listed for 1.47 . The volume for the day was 1.1 M. This history from September 5, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 1.99% . The trading delta at closing time to the current price is 2.65% . |
ImmuPharma PLC Fundamentals Correlations and Trends
By evaluating ImmuPharma PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ImmuPharma PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ImmuPharma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ImmuPharma PLC Stock history
ImmuPharma PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmuPharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmuPharma PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmuPharma PLC stock prices may prove useful in developing a viable investing in ImmuPharma PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 362 M | 380.1 M | |
| Net Loss | -7.4 M | -7 M |
ImmuPharma PLC Stock Technical Analysis
ImmuPharma PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ImmuPharma PLC Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
ImmuPharma PLC cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ImmuPharma PLC December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how ImmuPharma PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImmuPharma PLC shares will generate the highest return on investment. By undertsting and applying ImmuPharma PLC stock market strength indicators, traders can identify ImmuPharma PLC entry and exit signals to maximize returns
ImmuPharma PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ImmuPharma PLC's price direction in advance. Along with the technical and fundamental analysis of ImmuPharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmuPharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (0.91) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ImmuPharma Stock analysis
When running ImmuPharma PLC's price analysis, check to measure ImmuPharma PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuPharma PLC is operating at the current time. Most of ImmuPharma PLC's value examination focuses on studying past and present price action to predict the probability of ImmuPharma PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuPharma PLC's price. Additionally, you may evaluate how the addition of ImmuPharma PLC to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world |